(S)-BI 665915 is an orally active, oxadiazole-containing 5-lipoxygenase-activating protein (FLAP) inhibitor that binds to FLAP with an IC50 of 1.7 nM; it inhibits FLAP function in human whole blood with an IC50 of 45 nM and demonstrates potent, dose-dependent inhibition of LTB4 production along with favorable cross-species metabolic and pharmacokinetic (DMPK) profiles.